Back

When innovation and evidence disrupt the TAVI landscape

30 August 2025 (15:33 - 15:45)
Organised by: Logo
Congress Presentation Part of: How the new guidelines and innovations impact the daily management of patients with heart valves diseases Valvular Heart Disease Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Nicolas van Mieghem

Hospital Oost-Limburg (ZOL), Genk (Belgium)

4 More presentations in this session

Presentation thumbnail
Session introduction
Professor B. Assmus (Giessen, DE) Professor D. Capodanno (Catania, IT)
Presentation thumbnail
New Guidelines and their impact on heart valve therapies
Professor R. von Bardeleben (Mainz, DE)
Presentation thumbnail
When durable TEER outcomes are supported by proven technologies
Professor M. Kessler (Ulm, DE)
Presentation thumbnail
Key learnings
Professor B. Assmus (Giessen, DE) Professor D. Capodanno (Catania, IT)

Access the full session

Session thumbnail
How the new guidelines and innovations impact the daily management of patients with heart valves diseases

The Event

Event poster

ESC Congress 2025

30 August 2025 15:33 CET
You may be interested in
thumbnail
Congress Session
ESC Paul Hugenholtz Lecture in Innovation
25 August 2023
thumbnail
ESC TV Today
Episode 12: Relevance and management of ventricular ectopic beats - Lp(a) in cardiovascular risk management
27 March 2025
thumbnail
Congress Session
Cardiac pacing and cardiac resynchronisation therapy
30 March 2025
thumbnail
Congress Presentation
Percutaneous devices for valve repair and replacement
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources